QIAGEN powered by

Webinars and events

Loading Events

« All Events

  • This event has passed.

Pathway and network analysis on different types of lists with QIAGEN IPA

May 16, 2023 @ 1:00 pm - 2:30 pm

You may not have a typical transcriptomics dataset (i.e., a list of genes with differential expression), yet, you’d like to analyze a list of IDs. In this training, we will explore how to perform pathway and network analysis for lists of IDs in QIAGEN IPA.
Examples of lists that we’ll explore include:
• A gene/protein/metabolite list coming from a paper, generated in a lab or from a collaborator without differential expression
• A list of RS IDs for variants with or without numerical values such as p-values
• A list of proteins with Z-score (or other numerical value) calculated outside of IPA
• Other lists where you have mainly IDs and but no differential expression data

In this IPA training, you’ll learn how to:
• Upload and perform a pathway analysis (also known as core analysis) on a list of genes, proteins, metabolites or other types of IDs
• Open and investigate pathways and networks for understanding biological mechanisms
• Compare between analyses to identify similarities and differences for applications such as biomarker discovery
• Generate a custom network and contextualize it using public data


Date: May 16, 2023
 1:00 pm - 2:30 pm
Register for event
Event Categories:
Event Tags:


Virtual – Americas – EST
United States


Discovery, Webinar
Register for event

On-demand Webinars

  • Supercharge your AI in drug discovery with high-quality biomedical data

    If you’re working in pharma or biotech, you likely rely on artificial intelligence (AI) to help you identify new drug targets or plausible biomarkers for disease within large data sets. Yet AI alone isn’t enough. A large proportion of Biomedical data have errors and are unstructured. For AI models to provide reliable insights, the underlying data must be of ‘hig...

  • Scale up NGS bioinformatics analysis throughput with QIAGEN CLC Genomics cloud computing

    Scale your NGS analysis to match your sequencing throughput using our QIAGEN CLC Genomics cloud solution. In this webinar, you’ll learn about the flexible and powerful setup for running your NGS sequence analyses on Amazon Web Services (AWS). You’ll learn how to use QIAGEN CLC Genomics Workbench to customize workflows and send analyses to AWS Batch for execution. ...

  • QIAGEN Biomedical Knowledge Base: Data- and analytics-driven drug discovery

    Biomedical relationships knowledge is now required for innovative data- and analytics-driven drug discovery. It powers biomedical knowledge graph analysis, artificial intelligence (AI)-driven target identification and many more applications. In this one-hour training, you’ll get an introduction to QIAGEN Biomedical Knowledge Base. You’ll learn how to tackle appli...

  • Part 1: AI-Powered Hereditary Disease Diagnostics: Closing the Gap in Clinical Exome Completeness

    Clinical exome sequencing (CES) is increasingly being adopted by small and mid-sized laboratories to diagnose genetic diseases, aid treatment decisions, and provide prognostic information. However, the exponential increase in genetic data generated from exome and genome panels poses significant workflow challenges. The ability to prioritize potentially pathogenic vari...

  • A breakthrough for rare disease: Completing the Clinical exome gap!

    In its latest release, QCI Interpret for Hereditary extends its market-leading content with further advancements in Artificial Intelligence (AI) for enhanced capabilities in clinical exome NGS testing. Now, with the addition of AI-derived literature references for rare disease genes, QCI Interpret provides complete exome coverage, on top of the existing unrivalled man...

  • What’s new in QIAGEN IPA Fall Release 2023?

    Interested in learning about new features and functionalities that have been added to IPA lately? During this webinar, we will highlight the updates from the QIAGEN IPA Fall Release and from previous releases from this year. Topics, amongst others, will be • Newly added findings and pathways • Reactome pathways • Artificial intelligence approves to pathways ...